61 related articles for article (PubMed ID: 10778174)
1. [Sialyl SSEA-1 (SLX)].
Harada Y; Endo J
Nihon Rinsho; 1999 Dec; 57 Suppl():502-5. PubMed ID: 10778174
[No Abstract] [Full Text] [Related]
2. [SLX (sialyl SSEA-1, sialyl Le(x)-i)].
Kannagi R; Izawa M; Koike T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():675-80. PubMed ID: 16149609
[No Abstract] [Full Text] [Related]
3. [SLX(sialyl SSEA-1, sialyl Le(x)-i)].
Kannagi R; Izawa M; Sakuma K
Nihon Rinsho; 2010 Jul; 68 Suppl 7():720-5. PubMed ID: 20960856
[No Abstract] [Full Text] [Related]
4. [Clinical significance of sialyl SSEA-1 assay as a tumor marker].
Endo J; Nagaoka S; Kannagi R
Nihon Rinsho; 1990 Feb; 48 Suppl():1008-12. PubMed ID: 1972417
[No Abstract] [Full Text] [Related]
5. [2-->6 Sialyl Le(a) antigen].
Miyazaki K; Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():663-8. PubMed ID: 16149606
[No Abstract] [Full Text] [Related]
6. Use of multiple markers to enhance clinical utility.
Mercer DW
Immunol Ser; 1990; 53():39-54. PubMed ID: 2100569
[No Abstract] [Full Text] [Related]
7. Advantage of cocktail-use of two anti-tumor monoclonal antibodies, KM-93 and KM-231, in serum diagnosis of cancer.
Shitara K; Hanai N; Furuya A; Yoshida H
Anticancer Res; 1989; 9(4):999-1004. PubMed ID: 2479331
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of sialyl SSEA-1 (SLX) in patients with idiopathic interstitial pneumonia].
Totani Y; Demura Y; Ameshima S; Miyamori I; Ishizaki T
Nihon Kokyuki Gakkai Zasshi; 2001 Apr; 39(4):238-43. PubMed ID: 11481821
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of preoperative serum sialyl Lewis X-i antigen levels in non-small cell lung cancer.
Satoh H; Ishikawa H; Yamashita YT; Takahashi H; Ishikawa S; Kamma H; Ohtsuka M; Hasegawa S
Anticancer Res; 1998; 18(4B):2865-8. PubMed ID: 9713476
[TBL] [Abstract][Full Text] [Related]
10. [CA72-4 (TAG-72)].
Maida Y; Kyo S; Inoue M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():672-4. PubMed ID: 16149608
[No Abstract] [Full Text] [Related]
11. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.
Mizuguchi S; Nishiyama N; Iwata T; Nishida T; Izumi N; Tsukioka T; Inoue K; Uenishi T; Wakasa K; Suehiro S
Lung Cancer; 2007 Dec; 58(3):369-75. PubMed ID: 17697728
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
J Surg Oncol; 1996 Jul; 62(3):171-6. PubMed ID: 8667623
[TBL] [Abstract][Full Text] [Related]
13. [CA50].
Kawabe T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():645-6. PubMed ID: 16149601
[No Abstract] [Full Text] [Related]
14. [Pancreatic cancer and tumor markers].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1991 Jun; Suppl 89():58-72. PubMed ID: 1680205
[No Abstract] [Full Text] [Related]
15. [CA19-9].
Odagiri E
Nihon Rinsho; 2005 Aug; 63 Suppl 8():642-4. PubMed ID: 16149600
[No Abstract] [Full Text] [Related]
16. [The pre- and postoperative and follow-up use of the tumor markers MCA, CA-125 and CA-19-9].
Zanon C; Alluminio P; Margarita V; Sottimano C; Giuliani F; Neri G; Ballario F
Minerva Chir; 1992 Jan; 47(1-2):27-30. PubMed ID: 1553049
[TBL] [Abstract][Full Text] [Related]
17. [STN (sialyl Tn antigen)].
Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():659-62. PubMed ID: 16149605
[No Abstract] [Full Text] [Related]
18. [Sialyl Tn antigen].
Kannagi R
Nihon Rinsho; 1999 Dec; 57 Suppl():482-7. PubMed ID: 10778170
[No Abstract] [Full Text] [Related]
19. [Gallbladder carcinoma producing CEA, AFP, CA19-9, sialyl SSEA and CSF].
Tanigawa N
Ryoikibetsu Shokogun Shirizu; 1996; (9):237-9. PubMed ID: 8705462
[No Abstract] [Full Text] [Related]
20. [STN (sialyl Tn antigen)].
Kannagi R
Nihon Rinsho; 2010 Jul; 68 Suppl 7():698-702. PubMed ID: 20960853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
